Cabinet alternative,software economics.
Pricing for serious IP work. Calibrated against €18–45k/yr cabinet FTO retainers, €50k/yr Reaxys seats, and the €5–50M you spend per litigation. Big Pharma economics, indexed to outcomes — not Big Pharma billing.
Annual is 12× the monthly rate. No discount theatre.
Founder
For one inventor, one cluster.
- 10 landscapes / mo
- 5 PROV drafts / mo
- US / EP coverage
- 50 FTO scans / mo
- Email support
- Standard SLA
Scale
For the biotech building a portfolio.
- 100 landscapes / mo
- 50 PROV drafts / mo
- Multi-juris CIL — US / EP / JP / CN / UK / FR
- 1,000 FTO scans / mo
- Dedicated FTO obsessionnel
- Priority support
- 99.9% SLA
Enterprise
For the platform writing the patent map.
- Unlimited landscapes, drafts and FTO scans
- On-prem option
- Full CIL trade-secret access
- Dedicated patent strategist
- White-label deliverables
- Slack channel
- 99.99% SLA
- Custom legal-cartography updates
Compare against the alternatives: €18–45k / yr for cabinet FTO, €50k / yr Reaxys, and €5–50M per litigation. IPZilla rolls all three into one workflow.
Feature matrix
Every entitlement, line by line.
What sits behind each tier, including jurisprudence coverage (G 2/21, Amgen, UPC CoA 528/2024) and CIL access depth.
| Feature | Founder€2,400 /mo | Scale€19,200 /mo | Enterprise€144,000 /mo |
|---|---|---|---|
| Coverage | |||
Jurisdictional CIL Claim Interpretation Lattice across patent offices | US / EP | US / EP / JP / CN / UK / FR | Global + custom |
Patent corpus Indexed full-text + family graph | 130M patents | 130M + literature | 130M + custom corpora |
69-failure legal cartography G 2/21, Amgen §112, UPC CoA 528/2024, … | Included | Included | Included |
| Quotas | |||
Landscapes / month | 10 | 100 | Unlimited |
PROV drafts / month | 5 | 50 | Unlimited |
FTO scans / month | 50 | 1,000 | Unlimited |
Inventors / seats | 1 | 10 | Unlimited |
| Drafting capabilities | |||
PROV (US provisional) drafting | Included | Included | Included |
Full application drafting | Not included | Included | Included |
Cascade-4-couches claim sets Independent / dependent / fall-back / poisoning-aware | Standard | Advanced | Custom + reviewed |
INPI / EPO / USPTO export | Included | Included | Included |
Doctrine-of-equivalents simulator | Not included | Included | Included |
| Intelligence access | |||
CIL trade-secret tier Internal interpretation traces, not in published claims | Not included | Partial | Full access |
Custom legal-cartography updates New jurisprudence patched on request | Not included | Not included | Included |
Dedicated patent strategist | Not included | FTO obsessionnel | Strategist + counsel |
| Support & SLA | |||
Support channel | Priority email | Slack channel | |
First-response SLA | 48h | 4h | 1h |
Uptime SLA | Standard | 99.9% | 99.99% |
Onboarding | Self-serve | Guided | White-glove |
| Compliance & deployment | |||
On-prem option | Not included | Not included | Included |
White-label deliverables | Not included | Not included | Included |
GDPR — EU data residency | Included | Included | Included |
SOC 2 / ISO 27001 | Type I | Type II | Type II + audit |
DPA + SCCs | Included | Included | Included |
Annual prices are simply 12× monthly. Quotas are computed on the calendar month and reset on the first.
FAQ
Questions worth answering precisely.
Why these prices?
How does IPZilla compare to a patent cabinet?
How does the CIL trade-secret access work for Enterprise?
Can I upgrade mid-year?
Is there a discount?
How do PROV drafts get filed?
What happens to my data?
GDPR + sovereignty for EU clients?
Still have a question? Write to hello@ipzilla.app.
Beyond Enterprise
Need more? On-prem, sovereign clouds, custom CIL axes — we build it.
For Big Pharma R&D groups, sovereign biotech programs, and platform companies running their own patent map: pricing scales with throughput, jurisdictions, and the depth of CIL trade-secret access. Talk to a strategist.